Lombard Odier Asset Management (Europe)’s PDL BioPharma, Inc. PDLI Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,677	Closed	-$50K	–	488
2017 Q3	$50K	Hold	14,677	–	–	﹤0.01%	441
2017 Q2	$36K	Hold	14,677	–	–	﹤0.01%	431
2017 Q1	$33K	Hold	14,677	–	–	﹤0.01%	405
2016 Q4	$31K	Hold	14,677	–	–	0.01%	354
2016 Q3	$49K	Hold	14,677	–	–	0.02%	385
2016 Q2	$46K	Buy	+14,677	New	+$48.9K	﹤0.01%	404

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s PDLI Position: Q4 2017 in Review

Lombard Odier Asset Management (Europe) sold out of PDL BioPharma, Inc. (PDLI) in Q4 2017, closing a stake of 14,677 shares — an estimated $50K sold.

Lombard Odier Asset Management (Europe) first reported a position in PDLI in Q2 2016 and held it in 6 quarters. The position peaked at $50K in Q3 2017. 187 funds tracked by Wall St. Rank hold PDLI as of Q4 2017.

Lombard Odier Asset Management (Europe) reported no remaining PDL BioPharma, Inc. position as of Q4 2017 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 14,677 PDL BioPharma, Inc. shares in Q4 2017, an estimated $50K.
Lombard Odier Asset Management (Europe) first reported a position in PDL BioPharma, Inc. in Q2 2016 and held it in 6 quarters.
Lombard Odier Asset Management (Europe)'s PDL BioPharma, Inc. position peaked at $50K in Q3 2017.
187 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2017.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q4 2017, filed 13 Feb 2018.